A stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of ...

By Dominique Patton PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% ...

PAI Partners has submitted an improved offer for Sanofi’s consumer health business, according to people familiar with the ...

A consortium led by French private equity firm PAI Partners has submitted a new, higher offer for Sanofi's consumer health ...

Sanofi is in talks with CD&R to sell a 50% stake in its consumer healthcare unit, Opella. PAI Partners raised its bid by 200 ...

PAI Partners raises offer for Sanofi's consumer health unit, Opella, by €200 million and aims to keep key operations in ...

PAI partners submitted an improved bid for Sanofi's consumer health business, in an attempt to reenter the race for what could be one of the pharma industry's biggest deals this year.

Sanofi and private equity firm CD&R are in negotiations to sell a 50% stake in Opella, Sanofi's consumer healthcare division. With a €16B valuation, Opella is the third-largest player in the global ...

PAI Partners has been working with sovereign wealth funds Abu Dhabi Investment Authority and Singapore’s GIC Pte on the bid for Opella, the people said. The improved offer is valid until 6 p.m ...

PAI Partners has submitted an improved offer for Sanofi’s consumer health business, according to people familiar with the matter, an unexpected twist in one of the biggest deals in Europe this year.

A consortium led by French private equity firm PAI Partners has submitted an increased offer for Sanofi's (SASY) consumer health ...

Sanofi will sell a 50% controlling stake in consumer healthcare unit Opella to private equity firm CD&R, with the French ...